<DOC>
	<DOC>NCT02446990</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of ivabradine on cardiovascular events in patients with coronary artery disease.</brief_summary>
	<brief_title>Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Evidence of coronary artery disease Sinus rhythm and resting heart rate equal or higher than 70 bpm Unstable cardiovascular condition Known hypersensitivity to ivabradine or current treatment with marketed ivabradine</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>